An Indian biotech company aims to restore vision

Ever thought an Indian company could be developing a drug that restores vision? That could soon be the case with Eyestem Research, a Bengaluru- and US-based biotech company working on cell therapy for retinal diseases. Its lead program, Eyecyte-RPE, is designed to treat Geographic Atrophy—the advanced stage of dry age-related macular degeneration (AMD), a leading cause of blindness in people over 50. Globally, around 19.6 crore people live with AMD, of which nearly 50 lakh suffer from GA.